Press release
AI in Respiratory Diseases Market Key Players Analysis - Siemens Healthineers, VIDA Diagnostics Inc,THIRONA, Infervision, icometrix. GE Healthcare.
AI in Respiratory Diseases Market
According to the latest research by InsightAce Analytic, the Global AI in Respiratory Diseases Market is expected to show a CAGR of 29.4% during a forecast period of 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2055
Artificial Intelligence (AI) has made significant advancements in the diagnosis, management, and research of respiratory diseases, providing innovative solutions that enhance patient care and improve outcomes. Diagnostic techniques for respiratory conditions are crucial in identifying and addressing issues at their earliest and most treatable stages.
The growth of the AI in Respiratory Diseases market is primarily driven by the critical role of high-resolution computed tomography (CT) in diagnosing fibrotic lung diseases. For example, idiopathic pulmonary fibrosis can now be diagnosed without the need for a lung biopsy if high-resolution CT scans reveal characteristics consistent with those of usual interstitial pneumonia. Additionally, the rising prevalence of chronic diseases and respiratory issues continues to contribute to the growing adoption of AI in the treatment of respiratory conditions worldwide.
The rapid expansion of healthcare data, driven by innovations in digital tools such as genomics, diagnostic imaging, and electronic health records, has resulted in a significant increase in the volume and complexity of information. This surge in data has led to the development of numerous AI-based applications with direct therapeutic implications. However, the growth of the market may face challenges, including consumer unawareness of alternative treatment options for lung infections, which could limit broader adoption of AI solutions in respiratory care.
List of Prominent Players in the AI in Respiratory Diseases Market:
• ArtiQ
• Dectrocel Healthcare
• DeepMind Health
• GE Healthcare
• Icometrix
• Infervision
• Philips Healthcare
• PneumoWave
• Respiray
• Siemens Healthineers
• Swaasa AI
• THIRONA
• Verily
• VIDA Diagnostics Inc
• Zynnon
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics:
Drivers:
The increasing demand for Artificial Intelligence (AI) in respiratory diseases is largely driven by the growing need for personalized care. The global shift towards individualized treatment strategies is significantly contributing to the expansion of AI applications in the management of respiratory conditions. Medical interventions for respiratory diseases are becoming more tailored to patients' unique characteristics, including genetics, lifestyle, and environmental factors. This trend is expected to drive the demand for AI technologies in the treatment of respiratory diseases in the coming years.
Challenges:
A primary challenge in the market is the lack of familiarity with alternative treatment methods, stringent regulatory frameworks, and concerns over the adverse effects of drugs, particularly in emerging markets affected by lockdowns and isolation measures. These factors are anticipated to slow the growth of AI applications in respiratory disease management. Nevertheless, the global rise in chronic conditions such as diabetes, cancer, heart disease, and respiratory ailments like chronic obstructive pulmonary disease (COPD) remains a significant driver for the integration of AI into respiratory care. Additionally, the COVID-19 pandemic has underscored the critical role of AI in addressing medical emergencies and advancing the understanding of complex diseases, further accelerating the adoption of AI in respiratory medicine.
Regional Trends:
The North American AI in respiratory diseases market is expected to capture a significant share of the global market, driven by substantial revenue generation. The region is projected to experience robust growth in the near future, supported by advancements in AI technologies developed locally and significant investments in research and development within the pharmaceutical sector. The ongoing innovation in the pharmaceutical industry, coupled with rising public awareness, is fueling the demand for AI applications in respiratory care in North America.
Europe is also witnessing notable market share due to increased availability of medications, heightened consumer awareness, and the growing popularity of AI in respiratory disease management. Additionally, the presence of key market players and the rising collaboration between major stakeholders in the region offer significant opportunities for the expansion of the AI in respiratory diseases market on a global scale.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2055
Recent Developments:
• In August 2023, Siemens Healthineers introduced the Acuson Origin1, a cardiovascular ultrasound system equipped with advanced AI functions. By addressing diagnostic, structural heart, electrophysiological, and pediatric treatments, the Acuson Origin aims to enhance patient outcomes and aid clinicians in performing minimally invasive cardiac procedures more effectively.
• In Nov 2021, A collaborative agreement has been established between GE Healthcare and Optellum with the aim of advancing the precision diagnosis & treatment of lung cancer. The collective efforts of these firms aim to tackle a significant obstacle in the detection of lung cancer, specifically aiding healthcare personnel in accurately assessing the cancerous nature of a lung nodule.
Segmentation of AI in Respiratory Diseases Market-
By Indication-
• Chronic Obstructive Pulmonary Disease
• Interstitial Lung Disease
• Pulmonary Infection
By Imaging Type -
• MRI
• CT Scan
• ePRO
By End-use -
• Hospital
• Diagnostic Centers
• Ambulatory Surgical centers
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/ai-in-respiratory-diseases-market/2055
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Respiratory Diseases Market Key Players Analysis - Siemens Healthineers, VIDA Diagnostics Inc,THIRONA, Infervision, icometrix. GE Healthcare. here
News-ID: 4005117 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
